Proposal:REFUND Act of 2019

This proposal is archived and closed to further debate. It was introduced in the 116th Congress, which has concluded, and the bill was not enacted into law.

Bill	S 551
Type of Legislation	Senate Bill
Congress	116
Source	View original on Congress.gov

Geographic Scope

National

Description

Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 or the REFUND Act of 2019

This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) in relation to discarded amounts (i.e., amounts remaining after administration) of single-dose vial drugs that are covered under Medicare. Manufacturers that fail to comply are subject to civil penalties.

The CMS must determine rebate amounts based on payment claims from providers. (Currently, providers may receive payment under Medicare for discarded amounts of single-dose vial drugs through the use of a specific claims modifier.)

Bill Title

REFUND Act of 2019

Linked Goals

• Goal:Promote General Welfare

Steps

• 2019-02-25: Read twice and referred to the Committee on Finance. (text: CR S1439)
• 2019-02-25: Introduced in Senate

Projected Outcome

A more informed proposal or public response aligned with the Promote General Welfare goal.